Gimv portfolio
Gimv has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Kinaset Therapeutics's $103M Series B+ round in January 2026, alongside Willett Advisors LLC, Vivo Capital, Sixty Degree Capital and 6 others. That company is in Health and bio. It has co-invested with Atlas Venture, Schroders Capital and RA Capital Management, most often Atlas Venture (2 rounds).
What Gimv invests in
- Health and bio · 1 · 100%
How Gimv invests
Share is of the 2 rounds on Recent Funding that name Gimv. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Gimv portfolio companies
KKinaset Therapeutics$103MSeries B+ · Jan 2026
| Company | Round with Gimv | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $103M | $143M | Jan 9, 2026 Series B+ |
Most frequent co-investors
AAtlas Venture2 shared rounds · last Jan 9, 2026
SSchroders Capital1 shared round · last Jan 9, 2026
RRA Capital Management1 shared round · last Jan 9, 2026
WWillett Advisors LLC1 shared round · last Jan 9, 2026
VVivo Capital1 shared round · last Jan 9, 2026
SSixty Degree Capital1 shared round · last Jan 9, 2026
PPictet Alternative Advisors1 shared round · last Jan 9, 2026
FForge Life Science Partners1 shared round · last Jan 9, 2026
EEQT Life Sciences1 shared round · last Jan 9, 2026
55AM Ventures1 shared round · last Nov 30, 2020
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moDDeepWork Capital1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Gimv, which is a subset of its real portfolio. API: /api/v1/investors/gimv (get a free API key). More: the most active VC firms and new venture capital funds.